Jessica Sack

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors

Marianna Yaron, Elena Izkhakov, Jessica Sack et al. · Pituitary · 2016 · 30 citations

Metabolic Syndrome, Vascular Disease, Cardiovascular Disease +12

Inhibition of Intimal Thickening in the Rat Carotid Artery Injury Model by a Nontoxic Ras Inhibitor

Jacob George, Jessica Sack, Iris Barshack et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 22 citations · Full text

Multidisciplinary Treatment of the Metabolic Syndrome Lowers Blood Pressure Variability Independent of Blood Pressure Control

Yonit Marcus, Elad Segev, Gabi Shefer et al. · Journal of Clinical Hypertension · 2015 · 22 citations · Full text

Hypertension, Metabolic Disorder, Blood Pressure +16

Insulin-degrading enzyme higher in subjects with metabolic syndrome

Yael Sofer, Yuval Nash, Esther Osher et al. · Endocrine · 2021 · 20 citations

Obesity, Metabolic Syndrome, Metabolic Disorder +9